Amarantus Bioscience Holdings Inc (AMBS)

[Sccrbrg]

That particular argument has nothing to do with market cap.

There's an investor sentiment facet that you're entirely missing.

Would you pay $15 a share for a company with a history of stretching the truth, missing deadlines, and no proven product?

Yes, I'm aware of the ratios and the market cap. That's not rocket science. But this would never make it to $15 a share.


What is a mystery and may well be rocket science is how gerald brings in 750K every two years but only holds 1% (1 million dollars) of common stock.

That is not how you tie executive compensation to shareholder interests.